2017 Annual Meeting
SC48-Problematic Areas in the Pathology of the Uterine Cervix
March 8 2017, 1:30pm to 5:30pm
SC48-Problematic Areas In The Pathology Of The Uterine Cervix
Session Credits: 3 CME and 3 SAMs
Faculty: Esther Oliva MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA and Carmen Tornos MD, Stony Brook University Hospital, Stony Brook, NY
The goal of this course is to review in depth selected common and uncommon lesions, benign, preneoplastic and neoplastic, that involve the uterine cervix highlighting useful morphologic and immunohistochemical features, and as a result enhance the diagnostic skills of course participants. The course is intended for pathology residents, general pathologists as well as pathologists with a special interest in gynecologic pathology. The following material will be provided: Aperio scanned slides; questions in test format pre-course that will be compared to post-course test as well as powerpoint presentation and written handout with references.
Upon completion of this educational activity the participants should be able to distinguish:
- Squamous dysplasia from atrophy/transitional metaplasia; reactive atypia /repair /artifact related changes, and immature squamous metaplasia
- Invasive squamous carcinoma from florid squamous metaplasia, florid endocervical gland involvement by in situ carcinoma, postbiopsy pseudoinvasion, other neoplasms (adenoid basal carcinoma and trophoblastic tumors), and decidual change
- Adenocarcinoma in situ from reactive changes, tuboendometrioid metaplasia/ endometriosis, glandular colonization by squamous dysplasia, early invasive adenocarcinoma, and extension from endometrial carcinoma (endometrial vs endocervical)
- Adenocarcinoma subtypes
- Adenoma malignum from lobular glandular hyperplasia, endocervicosis and other benign lesions
- Clear cell carcinoma from microglandular hyperplasia, Arias-Stella reaction, radiation atypia, and mesonephric proliferations
- Non-epithelial lesions including pseudolymphoma from lymphoma and stromal polyps from rhabdomyosarcoma and adenosarcoma.